Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease. Implications for its use?

Author： Deneberg Stefan Lerner Richard Ljungman Per Ringden Olle Hägglund Hans

ISSN： 1357-0560

Source： Medical Oncology, Vol.24, Iss.3, 2007-09, pp. : 354-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardizing chronic graft-versus-host disease

By van Besien Koen

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 459-462

Future Medicine

Access to resources Recommend Favorite

Soft Tissue Sarcoma in the Setting of Chronic Cutaneous Graft Versus Host Disease After Allogenic Bone Marrow Transplantation

By Bylund Kevin Giampoli Ellen Singh Deepinder Doerr Timothy Sahasrabudhe Deepak Liesveld Jane Constine Louis

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 638-641

Informa Healthcare

Access to resources Recommend Favorite

Targeting CD83 for the treatment of graft-versus-host disease (Review)

By Wang Xiongfei Wei Ming Q. Liu Xiaosong

Experimental and Therapeutic Medicine, Vol. 5, Iss. 6, 2013-06 ,pp. : 1545-1550

Spandidos Publications

Access to resources Recommend Favorite

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

By Saillard Colombe Crocchiolo Roberto Furst Sabine El-Cheikh Jean Castagna Luca Signori Alessio Oudin Claire Faucher Catherine Lemarie Claude Chabannon Christian Granata Angela Blaise Didier

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1106-1112

Informa Healthcare

Access to resources Recommend Favorite

Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma

By El-Rayess Hebah M.

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1213-1214

Informa Healthcare

Access to resources Recommend Favorite